{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-017298","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.906464+00:00","generated_at":"2026-05-21T04:13:21.144098+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Windtree Q1 operating loss $4.1M, cash through May 2025; pivots to revenue via real estate","bullets":["Operating loss $4.1M vs $4.4M prior year; net loss $5.0M ($4.63/share) vs net income $10.2M in Q1 2024.","Cash and equivalents $1.2M at March 31, 2025; company believes funds operations only through May 2025.","Closed private placement of Series D convertible preferred for $2.6M gross proceeds in April/May 2025.","New strategy: secured right to buy a 436-unit multifamily property in Houston; signed supply agreement with Evofem for PHEXXI contraceptive gel.","Istaroxime cardiogenic shock study enrolled; interim analysis of first 20 subjects expected in Q3 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-017298","json":"https://secwatch.observer/filing/0001437749-25-017298.json","markdown":"https://secwatch.observer/filing/0001437749-25-017298.md","text":"https://secwatch.observer/filing/0001437749-25-017298.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774925017298/0001437749-25-017298-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774925017298/wint20250206_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:13:21.144098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}